Human SLCO1B1 and ApoE Gene Genotyping Detection Kit (PCR-Fluorescent Probe Method)

PCR-based fluorescence hybridization kit for genetic deafness gene detection and screening. Identifies hereditary hearing loss mutations through real-time PCR flow cytometry analysis, enabling early diagnosis and genetic counseling in clinical and research laboratories.

CE IVD real-time PCR kit for detection of APOE gene polymorphisms (*2A, *13, HapB3, c2846A>T) in human genomic DNA. Uses fluorescently labeled probes for genotyping according to CPIC and DPWG guidelines, enabling pharmacogenetic risk assessment for cardiovascular and neurodegenerative disease management.

CE IVD real-time PCR kit for apolipoprotein E genotyping in human genomic DNA. Enables detection of APOE polymorphisms relevant to cardiovascular and neurological disease risk assessment.

CE IVD real-time PCR kit for detection of APOB R3500Q mutation in human genomic DNA. Supports diagnosis of familial defective apolipoprotein B-100 and lipid disorder assessment.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

This product detects hereditary hypercholesterolemia risk-related genes including LDLR, APOB, PCSK9, LDLRAP1, ABCG5, and ABCG8, and simultaneously screens for drug-related genes SLCO1B1 and APOE to support clinical diagnosis and assessment.

CE IVD real-time PCR kit for detection of genetic polymorphisms and mutations in human genomic DNA using fluorescently labelled probes. Enables genotyping of pharmacogenetic variants including CYP2C19, TPMT, UGT1A1, and alpha-1 antitrypsin mutations for personalized medicine applications.

Genetic polymorphism detection kits for identifying genetic variations associated with drug metabolism, disease susceptibility, and therapeutic response. These in vitro diagnostic kits enable clinicians to personalize treatment decisions based on individual genetic profiles, supporting pharmacogenomics and precision medicine applications in clinical laboratories.

Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.

CE IVD real-time PCR kit for detection of lactase gene polymorphisms LCT (C13910T) and LCT (G22018A) in human genomic DNA using fluorescently labeled probes. Identifies lactose intolerance predisposition.

A targeted genetic test for detecting Alzheimer's disease risk genes, particularly APOE variants. This test assesses genetic predisposition to Alzheimer's disease for early intervention planning.

A diagnostic kit for genotyping of the human CYP2C19 gene.